Skip to main content

Table 3 Demographic characteristics and treatment antecedent of patients with- and without rifampicin resistance

From: Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014

Characteristics Patients with rifampicin resistance
(N = 79)
n (%)
Patients without rifampicin resistance
(N = 258)
n (%)
P value
Age (year) 0–14 0 (0) 2 (0.7) -----
 15–24 14 (17.7) 62 (24) 0.24
 25–34 26 (32.9) 92 (35.6) 0.65
 35–44 19 (24) 41 (15.9) 0.09
 45–54 9 (11.4) 33 (12.8) 0.74
  ≥ 55 7 (8.9) 22 (8.5) 0.92
Female 16 (20.2) 63 (24.4) 0.44
HIV+ 6 (7.6) 36 (13.9) 0.13
Previously Treated 69 (87.3) 32 (12.4) <0.01
AFB Negative 8 (10.1) 6 (2.3) <0.01
1+ or 2+ 15 (18.9) 21 (8.1) <0.01
3+ 55 (69.6) 222 (86) <0.01
  1. AFB acid fast bacilli, 1+ smear AFB positive at 1+, 2+ smear AFB positive at 2+, 3+ smear AFB positive at 3+